Search
Cisplatin Treatment Options in United Kingdom
A collection of 298 research studies where Cisplatin is the interventional treatment. These studies are located in the United Kingdom . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.
25 - 36 of 298
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Recruiting
This study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer. People can join the study if they have tumours with HER2 mutations and have not yet received any systemic therapy including chemotherapy for advanced or metastatic lung cancer. The purpose of this study is to find out whether a medicine called zongertinib (BI 1810631) can slow down the worsening of advanced non-small cell lung cancer better than the standard treatment available. Zongertinib ma... Read More
This study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer. People can join the study if they have tumours with HER2 mutations and have not yet received any systemic therapy including chemotherapy for advanced or metastatic lung cancer. The purpose of this study is to find out whether a medicine called zongertinib (BI 1810631) can slow down the worsening of advanced non-small cell lung cancer better than the standard treatment available. Zongertinib may slow cancer cell growth by inhibiting HER2. This would prolong cancer re-occurrence and increase survival. Current standard treatment is pembrolizumab plus platinum-pemetrexed chemotherapy.
Participants are put into 2 groups by chance. One group receives zongertinib at regular times throughout the study and the other group receives infusions of pembrolizumab, pemetrexed and cisplatin or carboplatin (pembrolizumab plus platinum-pemetrexed chemotherapy) into a vein.
Participants may be in the study up to a maximum of 70 months. During this time, they visit the study site about every 3 weeks for study procedures. The doctors regularly check the size of the tumour with a CT or MRI scan, at the beginning of the study and every 6 weeks. After 18 months they check the tumour size every 12 weeks. Doctors regularly check whether the cancer has spread to other parts of the body. The doctors also regularly check participants' health and take note of any unwanted effects. The time it takes for the cancer to worsen is compared between the 2 groups to see whether the treatment works. The participants also fill in questionnaires about their symptoms and quality of life. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/05/2025
Locations: Clearview Cancer Institute, Huntsville, Alabama +169 locations
Clearview Cancer Institute, Huntsville, Alabama
Mohtaseb Cancer Center and Blood Disorders, LLC, Bullhead City, Arizona
Precision NextGen Oncology, Beverly Hills, California
ClinRé 001-022 (Premier Cancer Care and Infusion Center), Fresno, California
OPN Healthcare, Inc., Glendale, California
Scripps Green Hospital, La Jolla, California
Valkyrie Clinical Trials, Los Angeles, California
Sharp Memorial Hospital, San Diego, California
St. Louis Cancer Care, LLP, Bridgeton, Missouri
Oncology Hematology Associates, Springfield, Missouri
Cancer Care Specialists, Reno, Nevada
Montefiore Medical Center, Bronx, New York
Northwell Health, Lake Success, New York
Regional Medical Oncology Center, Wilson, North Carolina
Gabrail Cancer Center, Canton, Ohio
Carolina Blood and Cancer Care Associates, PA, Rock Hill, South Carolina
SCRI Oncology Partners, Nashville, Tennessee
Huntsman Cancer Institute, Salt Lake City, Utah
Virginia Cancer Specialists, PC, Fairfax, Virginia
Swedish Cancer Institute, Edmonds, Washington
Swedish Cancer Institute, Issaquah, Washington
Swedish Cancer Institute, Seattle, Washington
Clinica Adventista Belgrano, Caba, Not set
Instituto Medico Especializado Alexander Fleming, Ciudad Autónoma de Bs As, Not set
Instituto Oncologico de Cordoba, Córdoba, Not set
Centro Oncologico Riojano Integral (CORI), La Rioja, Not set
Instituto Médico de la Fundación Estudios Clínicos, Rosario, Not set
Clinicas Viedma S.A., Viedma, Not set
Prince of Wales Hospital-Randwick-66496, Randwick, New South Wales
Royal North Shore Hospital-St Leonards-20807, St Leonards, New South Wales
Princess Alexandra Hospital, Woolloongabba, Queensland
Austin Health, Heidelberg, Victoria
St John of God Subiaco Hospital, Subiaco, Western Australia
Krems University Hospital, Krems an der Donau, Not set
Clinic Floridsdorf, Vienna, Not set
Brussels - HOSP Jules Bordet, Anderlecht, Not set
UNIV UZ Gent, Gent, Not set
UZ Leuven, Leuven, Not set
Associacao Dr. Bartholomeu Tacchini, Bento Goncalves, Not set
Hospital do Cancer de Londrina, Londrina, Not set
Hospital Sao Lucas da PUCRS, Porto Alegre, Not set
OncoClinicas Rio de Janeiro, Rio de Janeiro, Not set
CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia, Santo André, Not set
ICESP - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Not set
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, Not set
Princess Margaret Cancer Centre, Toronto, Ontario
Bradford Hill- Centro de Investigación Clínica, Recoleta, Not set
Cancer Hospital of Chinese Academy of Medical Science, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
West China Hospital of Sichuan University, Chengdu, Not set
Fujian Cancer Hospital, Fuzhou, Not set
Guangdong Provincial People's Hospital, Guangzhou, Not set
The First Affiliated Hospital, Zhejiang University, Hangzhou, Not set
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Harbin Medical University Cancer Hospital, Harbin, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Zhongshan Hospital Affiliated to Fudan University, Shanghai, Not set
Taizhou Hospital of Zhejiang Province, Taizhou, Not set
The First Affiliated Hospital of Wenzhou Med College, Wenzhou, Not set
Wuhan Union Hospital, Wuhan, Not set
First Affiliated Hospital of Xiamen University, Xiamen, Not set
Henan Cancer Hospital, Zhengzhou, Not set
HOP Louis Pradel, Bron, Not set
CTR Leon Berard, Lyon, Not set
HOP Nord, Marseille, Not set
HOP Tenon, Paris, Not set
INS Curie, Paris, Not set
HOP Pontchaillou, Rennes, Not set
HOP Civil, Strasbourg, Not set
INS Claudius Regaud IUCT-Oncopole, Toulouse, Not set
INS Gustave Roussy, Villejuif, Not set
Universitätsklinikum Augsburg, Augsburg, Not set
Gemeinschaftskrankenhaus Havelhöhe gGmbH, Berlin, Not set
Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Justus-Liebig Universität Gießen, Gießen, Not set
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg, Not set
Universitätsklinikum Köln (AöR), Köln, Not set
Pius-Hospital, Oldenburg, Oldenburg, Not set
Universitätsklinikum Tübingen, Tübingen, Not set
Queen Elizabeth Hospital-Hong Kong-51727, Hong Kong, Not set
Princess Margaret Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Koranyi National Institute For Pulmonolgy, Budapest, Not set
National Institute of Oncology, Budapest, Not set
Deszk Hospital of Chest Diseases, Deszk, Not set
Pulmonology Institute of Veszprem County, Farkasgyepu, Farkasgyepu, Not set
Fejer County Saint George University Teaching Hospital, Szekesfehervar, Not set
Rambam Medical Center, Haifa, Not set
Meir Medical Center, Kfar-Saba, Not set
Rabin Medical Center Beilinson, Petach Tikva, Not set
Sourasky Medical Center, Tel Aviv, Not set
Istituto Tumori Giovanni Paolo II, Bari, Not set
Istituto Di Candiolo, Candiolo (TO), Not set
AOU Policlinico G. Rodolico San Marco, Catania, Not set
Istituto Nazionale IRCCS Tumori Fondazione Pascale, Napoli, Not set
Azienda Ospedaliera Unversitaria di Parma, Parma, Not set
AOU Policlinico Umberto I, Roma, Not set
A. O. Ospedale Circolo Fond. Macchi, Varese, Not set
Aichi Cancer Center Hospital, Aichi, Nagoya, Not set
Hirosaki University Hospital, Aomori, Hirosaki, Not set
National Cancer Center Hospital East, Chiba, Kashiwa, Not set
Shikoku Cancer Center, Ehime, Matsuyama, Not set
Kyushu University Hospital, Fukuoka, Fukuoka, Not set
Hakodate Goryoukaku Hospital, Hokkaido, Hakodate, Not set
Hokkaido Cancer Center, Hokkaido, Sapporo, Not set
Kanazawa University Hospital, Ishikawa, Kanazawa, Not set
St. Marianna University Hospital, Kanagawa, Kawasaki, Not set
Kanagawa Cancer Center, Kanagawa, Yokohama, Not set
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Not set
Tohoku University Hospital, Miyagi, Sendai, Not set
Okayama University Hospital, Okayama, Okayama, Not set
Osaka International Cancer Institute, Osaka, Osaka, Not set
Shizuoka Cancer Center, Shizuoka, Sunto-gun, Not set
Juntendo University Hospital, Tokyo, Bunkyo-ku, Not set
Komagome Hospital, Tokyo, Bunkyo-ku, Not set
National Cancer Center Hospital, Tokyo, Chuo-ku, Not set
Japanese Foundation for Cancer Research, Tokyo, Koto-ku, Not set
Wakayama Medical University Hospital, Wakayama, Wakayama, Not set
Chungbuk National University Hospital, Cheongiu, Not set
National Cancer Center, Goyang, Not set
Gachon University Gil Medical Center, Incheon, Not set
Kangbuk Samsung Hospital, Seoul, Not set
Severance Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea, St.Vincent's Hospital, Suwon, Not set
Health Pharma Professional Research S.A. de C.V., Ciudad de Mexico, Not set
Centro Oncologico Personalizado, Mexico, Not set
Instituto Nacional de Cancerologia, Mexico, Not set
FAICIC S de RL de C.V., Veracruz, Not set
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam (METC AVL), Amsterdam, Not set
Maastricht University, Maastricht, Not set
Vestre Viken HF, Drammen Sykehus, Drammen, Not set
Oslo Universitetssykehus HF, Radiumhospitalet, Oslo, Not set
Polish Mother's Memorial Hospital - Research Institute, Lodz, Not set
Greater Poland Center of Pulmonology and Thoracic Surgery, Poznan, Not set
MED POLONIA SP Z O O, Clinical Trials Department,Poznan, Poznan, Not set
Oncology Center-Maria Sklodowska-Curie Institute, Warsaw, Not set
Hospital CUF Tejo, Lisboa, Not set
Centro Hospitalar Lisboa Norte Hospital Pulido Valente, Lisboa, Not set
Hospital CUF Porto, Porto, Not set
Pan American Center for Oncology Trials, LLC, Rio Piedras, Not set
National University Hospital-Singapore-22806, Singapore, Not set
National Cancer Centre Singapore, Singapore, Not set
Hospital A Coruña, A Coruña, Not set
Hospital General Universitario de Alicante, Alicante, Not set
Hospital Santa Creu i Sant Pau, Barcelona, Not set
Hospital Vall d'Hebron, Barcelona, Not set
Hospital de Basurto, Bilbao, Not set
Hospital Duran i Reynals, L'Hospitalet de Llobregat, Not set
Hospital General Universitario Gregorio Marañón, Madrid, Not set
Hospital Ramón y Cajal, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital La Paz, Madrid, Not set
Hospital Regional Universitario de Málaga, Málaga, Not set
Hospital Virgen del Rocío, Sevilla, Not set
Hospital Clínico de Valencia, Valencia, Not set
Sahlgrenska Universitetsjukhuset, Göteborg, Not set
Karolinska Universitetssjukhuset Solna, Stockholm, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
Chung Shan Medical University Hospital, Taichung, Not set
National Taiwan University Hospital, Taipei, Not set
National Taiwan University Cancer Center, Taipei, Not set
Chang Gung Memorial Hospital(Linkou), Taoyuan, Not set
Western General Hospital, Edinburgh, Not set
Leicester Royal Infirmary, Leicester, Not set
Guy's Hospital, London, Not set
The Royal Marsden Hospital, Chelsea, London, Not set
The Royal Marsden Hospital, Sutton, Sutton, Not set
Conditions: Lung Cancer, Non-squamous, Non-small Cell
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Recruiting
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma.
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/04/2025
Locations: Research Site, Phoenix, Arizona +179 locations
Research Site, Phoenix, Arizona
Research Site, Duarte, California
Research Site, Santa Rosa, California
Research Site, Aurora, Colorado
Research Site, Jacksonville, Florida
Research Site, Atlanta, Georgia
Research Site, Chicago, Illinois
Research Site, Baltimore, Maryland
Research Site, Rochester, Minnesota
Research Site, Saint Louis, Missouri
Research Site, East Brunswick, New Jersey
Research Site, Commack, New York
Research Site, Valhalla, New York
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Columbus, Ohio
Research Site, Independence, Ohio
Research Site, Portland, Oregon
Research Site, Portland, Oregon
Research Site, Portland, Oregon
Research Site, Philadelphia, Pennsylvania
Research Site, Houston, Texas
Research Site, Fairfax, Virginia
Research Site, Chermside, Not set
Research Site, Clayton, Not set
Research Site, Melbourne, Not set
Research Site, Nedlands, Not set
Research Site, Westmead, Not set
Research Site, Anderlecht, Not set
Research Site, Antwerpen, Not set
Research Site, Gent, Not set
Research Site, Hasselt, Not set
Research Site, Leuven, Not set
Research Site, Sint-Niklaas, Not set
Research Site, Barretos, Not set
Research Site, Fortaleza, Not set
Research Site, Joao Pessoa, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Santo Andre, Not set
Research Site, São Paulo, Not set
Research Site, Edmonton, Alberta
Research Site, Hamilton, Ontario
Research Site, London, Ontario
Research Site, Ottawa, Ontario
Research Site, Toronto, Ontario
Research Site, Montréal, Quebec
Research Site, Quebec, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Kunming, Not set
Research Site, Lanzhou, Not set
Research Site, Nanchang, Not set
Research Site, Ningbo, Not set
Research Site, Qingdao, Not set
Research Site, Shandong, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Taiyuan, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Tianjin, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Aarhus N, Not set
Research Site, Copenhagen, Not set
Research Site, Brest, Not set
Research Site, Creteil Cedex, Not set
Research Site, Le Mans Cedex, Not set
Research Site, Lille, Not set
Research Site, Lyon, Not set
Research Site, Marseille Cedex 20, Not set
Research Site, Montpellier, Not set
Research Site, Paris, Not set
Research Site, Rouen, Not set
Research Site, Saint Herblain, Not set
Research Site, Strasbourg, Not set
Research Site, Toulouse, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Bochum, Not set
Research Site, Essen, Not set
Research Site, Essen, Not set
Research Site, Gauting, Not set
Research Site, Georgsmarienhuette, Not set
Research Site, Grosshansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Heidelberg, Not set
Research Site, Kiel, Not set
Research Site, Köln, Not set
Research Site, Muenster, Not set
Research Site, Regensburg, Not set
Research Site, Alessandria, Not set
Research Site, Bari, Not set
Research Site, Bergamo, Not set
Research Site, Milan, Not set
Research Site, Monza, Not set
Research Site, Orbassano, Not set
Research Site, Padova, Not set
Research Site, Parma, Not set
Research Site, Rozzano, Not set
Research Site, Varese, Not set
Research Site, Amagasaki-shi, Not set
Research Site, Hakodate-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nishinomiya-shi, Not set
Research Site, Okayama-shi, Not set
Research Site, Osakasayama-shi, Not set
Research Site, Tokyo, Not set
Research Site, Ube-shi, Not set
Research Site, Cheongju-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Ulsan, Not set
Research Site, Amsterdam, Not set
Research Site, Eindhoven, Not set
Research Site, Rotterdam, Not set
Research Site, Lørenskog, Not set
Research Site, Oslo, Not set
Research Site, Bydgoszcz, Not set
Research Site, Bystra, Not set
Research Site, Olsztyn, Not set
Research Site, Poznań, Not set
Research Site, Rzeszów, Not set
Research Site, Warszawa, Not set
Research Site, Amanzimtoti, Not set
Research Site, Cape Town, Not set
Research Site, Johannesburg, Not set
Research Site, Johannesburg, Not set
Research Site, Kimberly, Not set
Research Site, Polokwane, Not set
Research Site, Pretoria, Not set
Research Site, Pretoria, Not set
Research Site, Barakaldo, Not set
Research Site, Barcelona, Not set
Research Site, Madrid, Not set
Research Site, Oviedo, Not set
Research Site, Baden, Not set
Research Site, Basel, Not set
Research Site, Bern, Not set
Research Site, Fribourg, Not set
Research Site, St. Gallen, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Adana, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Diyarbakir, Not set
Research Site, Izmir, Not set
Research Site, Cambridge, Not set
Research Site, Cardiff, Wales, Not set
Research Site, Leeds, Not set
Research Site, Leicester, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Newcastle-upon-Tyne, Not set
Research Site, Portsmouth, Not set
Research Site, Taunton, Not set
Conditions: Unresectable Pleural Mesothelioma
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Active Not Recruiting
The goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer.
The goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/04/2025
Locations: Alaska Oncology and Hematology LLC, Anchorage, Alaska +75 locations
Alaska Oncology and Hematology LLC, Anchorage, Alaska
Cancer & Blood Specialty Clinic, Los Alamitos, California
Moores Cancer Center at the UC San Diego Health, San Diego, California
Yale University Cancer Center, New Haven, Connecticut
ChristianaCare, Newark, Delaware
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida
Florida Cancer Affiliates, Ocala, Florida
Hope and Healing Cancer Services, Hinsdale, Illinois
University of Kentucky, Lexington, Kentucky
Norton Cancer Institute, Louisville, Kentucky
Maryland Oncology Hematology PA, Columbia, Maryland
Washington University School of Medicine, Saint Louis, Missouri
Levine Cancer Center, Charlotte, North Carolina
Novant Health Cancer Institute - Forsyth (Medical Oncology), Winston-Salem, North Carolina
Kaiser Permanente (KP) Oncology/Hematology, Portland, Oregon
University of Pennsylvania, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Sarah Cannon Research Institute, Nashville, Tennessee
Lumi Research, Kingwood, Texas
Utah Cancer Specialists, Salt Lake City, Utah
Virgina Cancer Specialists, Fairfax, Virginia
Adventist Health System/Sunbelt,Inc, Seattle, Washington
Medical Oncology Associates, PS, Spokane, Washington
Rigshospitalet (Copenhagen University Hospital), Copenhagen, Not set
Herlev University Hospital, Herlev, Not set
University Hospital of Southern Denmark, Vejle Hospital, Vejle, Not set
Centre hospitalier Universitaire de Bordeaux, Bordeaux, Not set
Centre Antoine Lacassagne, Nice, Not set
Gustave Roussy, Villejuif, Not set
ARENSIA Research Clinic at the Research Institute of Clinical Medicine, Tbilisi, Not set
Nationales Centrum fr Tumorerkrankungen NCT, Heidelberg, Not set
Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen, Not set
Department of Dermatology, University of Mainz, Mainz, Not set
Universitätsmedizin Mannheim Dermatologie, Mannheim, Not set
Universitaetsklinikum Wuerzburg, Wuerzburg, Not set
Rabin Medical Center, Petah tikva, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv, Not set
Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Not set
Azienda Ospedaliera S.Croce e Carle Cuneo, Cuneo, Not set
Istituto Nazionale dei Tumori, Milan, Not set
Istituto Clinico Humanitas, Rozzano, Not set
Chungbuk National University Hospital, Cheongju-si, Not set
Jeonbuk National University Hospital, Jeonju, Not set
Gachon University Gil Medical Center, Namdong, Not set
Korea University Guro Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Pusan National University Yangsan Hospital, Yangsan, Not set
ARENSIA Research Clinic at the Oncology Institute, Chisinau, Not set
H. Vall d'Hebron, Barcelona, Not set
START Barcelona HM Nou Delfos, Barcelona, Not set
Hospital Duran i Reynals - ICO L Hospitalet, L'Hospitalet De Llobregat, Not set
Hospital Universitario Insular de Gran Canaria, Las Palmas De Gran Canaria, Not set
Hospital Universitario Lucus Augusti, Lugo, Not set
Clinica Universidad de Navarra, Madrid, Not set
HM CIOCC Hospital Universitario HM Sanchinarro, Madrid, Not set
Hospital Clinico San Carlos, Madrid, Not set
Hospital General Universitario Gregorio Maran, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
MD Anderson Cancer Center Madrid, Madrid, Not set
START Madrid - Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario Virgen de la Victoria, Málaga, Not set
Clinica Universidad de Navarra, Pamplona, Not set
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago De Compostela, Not set
Hospital Virgen del Rocio, Sevilla, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Chang Gung Memorial Hospital (CGMH) - Kaohsiung Branch, Kaohsiung City, Not set
Kaohsiung Medical University Memorial Hospital, Kaohsiung City, Not set
China Medical University Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Medical University Hospital, Taipei, Not set
Taipei Veterans General Hospital, VGHTPE, Taipei, Not set
Chang Gung Memorial Hospital Linkou Branch, Taoyuan, Not set
Royal Marsden NHS Foundation Trust, Sutton, Not set
Conditions: Malignant Solid Tumor, Melanoma, Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-Small Cell Lung Cancer (NSCLC)
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
Active Not Recruiting
A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma.
A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Hoag Hospital, Irvine, California +43 locations
Hoag Hospital, Irvine, California
University of California San Diego, La Jolla, California
Cedar Sinai Medical Center, Los Angeles, California
University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida
Moffitt Cancer Center, Tampa, Florida
Rush University Medical Center, Chicago, Illinois
University of Louisville, Louisville, Kentucky
University of Maryland Medical System, Baltimore, Maryland
Memorial Sloan Kettering, New York, New York
The Ohio State University, Columbus, Ohio
Oregon Health & Science University/ Knight Cancer Institute, Portland, Oregon
Vanderbilt - Ingram Cancer Center, Nashville, Tennessee
Houston Methodist Cancer Center, Houston, Texas
Royal Brisbane and Womens Hospital, Herston, Queensland
Ashford Cancer Centre, Adelaide, South Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria
Sir Charles Gairdner Hospital, Nedlands, Not set
Cliniques Universitaires Saint-Luc, Bruxelles, Not set
AZ Groeninge, Kortrijk, Not set
Chungbuk National University Hospital, Cheongju-si, Not set
Yeungnam University Medical Center, Daegu, Not set
Gachon University (GCU) - Gil Medical Center (Gil Hospital), Incheon, Not set
CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center), Seongnam-si, Not set
Seoul National University, Bundang Hospital, Seongnam, Not set
The Catholic University of Korea - Eunpyeong St. Mary's Hospital, Seoul, Not set
Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Amsterdam UMC, Locatie VUMC, Amsterdam, Not set
Universitair Medisch Centrum Groningen, Groningen, Not set
National University Cancer Institute, Singapore, Not set
National Cancer Centre Singapore, Singapore, Not set
Institut Catala d Oncologia (ICO), Badalona, Not set
Hospital Universitari Dexeus, Barcelona, Not set
Institut Catala dOncologia, L'Hospitalet De Llobregat, Not set
Hospital Universitario Severo Ochoa, Leganés, Not set
Grupo Hospital de Madrid (HM) - Hospital Universitario Madrid Sanchinarro - Cent, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Regional Universitario de Malaga, Málaga, Not set
Hospital Universitario de Navarra, Pamplona, Not set
The Royal Marsden Hospital - Surrey, London, Not set
University College London Hospital, London, Not set
The Royal Marsden Hospital- London, London, Not set
Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
Completed
The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal adenocarcinoma than standard chemotherapy given before and after surgery and it can be safely administered.
The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal adenocarcinoma than standard chemotherapy given before and after surgery and it can be safely administered. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: University Hospital Gent, Gent, Vlaanderen +47 locations
University Hospital Gent, Gent, Vlaanderen
North Estonia Medical Centre, Tallinn, Not set
CHRU de Besancon - Hopital Jean Minjoz, Besançon, Not set
CHRU de Lille - Hopital Huriez, Lille, Not set
CHU de Bordeaux - Group Hospitalier Sud - Hopital Haut-Lévêque, Pessac, Not set
CHU de Reims - Hôpital Robert Debré, Reims, Not set
Institut Gustave Roussy, Villejuif, Not set
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Not set
Universitaetsklinikum Carl Gustav Carus, Dresden, Not set
Kliniken Essen-Mitte - Evang. Huyssens-Stiftung, Essen, Not set
Universitaetsmedizin Goettingen - Georg-August Universitaet, Göttingen, Not set
Asklepios Kliniken GmbH - Asklepios Klinik Barmbek, Hamburg, Not set
SLK-Kliniken Heilbronn GmbH, Heilbronn, Not set
Onkologische Unter-Ems (Leer-Papenburg-Emden), Leer, Not set
Universitaetsklinikum Leipzig, Leipzig, Not set
Johannes Gutenberg Universitaetskliniken - Mainz University Medical Center, Mainz, Not set
Ludwig-Maximilians-Universitaet München - Campus Grosshadern, München, Not set
Technische Universität München - Klinikum Rechts der Isar, München, Not set
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Not set
Istituto Europeo di Oncologia, Milano, Not set
Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Hallym University Sacred Heart Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Hallym University Sacred Heart Hospital, Seoul, Not set
Severance Hospital YUCM, Seoul, Not set
Severance Hospital, Yonsei University Health System (YUCM), Seoul, Not set
The Catholic University of Korea-St. Vincent's Hospital, Suwon-Si Gyeonggi-do, Not set
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Not set
Academisch Medisch Centrum - UMC Universiteit van Amsterdam - site: VUMC, Amsterdam, Not set
Oslo University Hospital - Radiumhospitalet, Oslo, Not set
Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisboa, Not set
Instituto Portugues De Oncologia - Centro Do Porto, Porto, Not set
National Cancer Centre Singapore, Singapore, Not set
Institut Catala d'Oncologia - ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona
ICO Badalona (Institut Catala d'Oncologia) - Hospital Germans Trias i Pujol, Badalona, Not set
Hospital Universitari Vall d'Hebron - Institut Oncologia, Barcelona, Not set
ICO Girona - Hospital Dr Josep Trueta (Institut Catala d'Oncologia), Girona, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
Hospital Clinico Universitario De Valencia, Valencia, Not set
Hôpitaux Universitaires de Genève - HUG, Geneve, Not set
Centre Hospitalier Universitaire Vaudois, Lausanne, Not set
University Hospitals Birmingham NHS - UHB-Queen Elisabeth MC, Birmingham, Not set
University College London Hospitals (UCLH) - NHS Foundation Trust, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Royal Marsden Hospital - site: Sutton, Surrey, Sutton, Not set
Conditions: Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Active Not Recruiting
The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, versus (vs) pembrolizumab plus maintenance pemetrexed for the treatment of non-squamous NSCLC. The study's 2 primary hypotheses are: 1. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance pemetrexed with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent clinical review (BICR) and 2. Pembrolizu... Read More
The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, versus (vs) pembrolizumab plus maintenance pemetrexed for the treatment of non-squamous NSCLC. The study's 2 primary hypotheses are: 1. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance pemetrexed with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent clinical review (BICR) and 2. Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance pemetrexed with respect to overall survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Alabama Oncology Bruno Cancer Center ( Site 0001), Birmingham, Alabama +177 locations
Alabama Oncology Bruno Cancer Center ( Site 0001), Birmingham, Alabama
Northwest Alabama Cancer Center, PC ( Site 0002), Muscle Shoals, Alabama
Disney Family Cancer Center ( Site 0005), Burbank, California
Boca Raton Regional Hospital ( Site 0018), Boca Raton, Florida
Mid-Florida Cancer Centers ( Site 0022), Orange City, Florida
Moffitt Cancer Center ( Site 0024), Tampa, Florida
Columbus Regional Research Institute ( Site 0098), Columbus, Georgia
Mount Sinai Hospital Medical Center ( Site 0032), Chicago, Illinois
Oncology of Northshore ( Site 0033), Rolling Meadows, Illinois
Methodists Hospitals/Premier Oncology Hematology Associates ( Site 0036), Merrillville, Indiana
Medstar Good Samaritan Hospital ( Site 0040), Baltimore, Maryland
Barbara Ann Karmanos Cancer Institute ( Site 0041), Detroit, Michigan
Hattiesburg Clinic ( Site 0045), Hattiesburg, Mississippi
Frontier Oncology ( Site 0080), Billings, Montana
Bozeman Health Deaconness Cancer Center ( Site 0046), Bozeman, Montana
Waverly Hematology Oncology ( Site 0081), Cary, North Carolina
Thompson Cancer Survival Center ( Site 2812), Knoxville, Tennessee
University of Tennessee Medical Center Knoxville ( Site 0060), Knoxville, Tennessee
Renovatio Clinical ( Site 0062), The Woodlands, Texas
Cancer Care Northwest ( Site 0071), Spokane Valley, Washington
Hospital Italiano Regional del Sur ( Site 0509), Bahia Blanca, Buenos Aires
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0511), Ciudad Autonoma de Buenos Aires, Buenos Aires
Hospital Britanico de Buenos Aires ( Site 0500), Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto Medico Rio Cuarto ( Site 0501), Rio Cuarto., Cordoba
Centro Oncológico de Rosario ( Site 0507), Rosario, Santa Fe
Centro Medico San Roque ( Site 0506), San Miguel de Tucuman, Tucuman
Clínica Universitaria Reina Fabiola ( Site 0505), Cordoba, Not set
Sanatorio Privado San Geronimo S.R.L ( Site 0510), Santa Fe, Not set
Liverpool Hospital ( Site 1201), Liverpool, New South Wales
Southern Medical Day Care Centre ( Site 1200), Wollongong, New South Wales
Townsville General Hospital ( Site 1202), Townsville, Queensland
Monash Cancer Centre ( Site 1205), Clayton, Victoria
Ordensklinikum Linz GmbH Elisabethinen ( Site 1307), Linz, Oberosterreich
Klinikum Wels-Grieskirchen ( Site 1304), Wels, Oberosterreich
Innsbruck LKH ( Site 1302), Innsbruck, Tirol
Social Medical Center - Otto Wagner Hospital ( Site 1301), Vienna, Wien
Krankenhaus Nord - Klinik Floridsdorf ( Site 1300), Wien, Not set
Hospital Sao Rafael ( Site 0212), Salvador, Bahia
Instituto do Cancer do Ceara ( Site 0201), Fortaleza, Ceara
Oncologica do Brasil ( Site 0210), Belem, Para
Hospital Tacchini ( Site 0208), Bento Goncalves, Rio Grande Do Sul
Irmandade da Santa Casa de Misericordia de Porto Alegre ( Site 0209), Porto Alegre, Rio Grande Do Sul
Saint Gallen Instituto de Oncologia ( Site 0206), Santa Cruz do Sul, Rio Grande Do Sul
YNOVA Pesquisa Clinica ( Site 0215), Florianopolis, Santa Catarina
Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 0202), Itajai, Santa Catarina
Centro de Hematologia e Oncologia ( Site 0205), Joinville, Santa Catarina
Hospital de Base de Sao Jose de Rio Preto ( Site 0204), Sao Jose Rio Preto, Sao Paulo
Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0203), Rio de Janeiro, Not set
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0200), Sao Paulo, Not set
BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 0214), Sao Paulo, Not set
Hospital Paulistano - Amil Clinical Research ( Site 0207), Sao Paulo, Not set
Lions Gate Hospital ( Site 0106), North Vancouver, British Columbia
BC Cancer - Victoria ( Site 0109), Victoria, British Columbia
Queen Elizabeth II Health Sciences Centre ( Site 0107), Halifax, Nova Scotia
Waterloo Regional Health Network (WRHN) ( Site 0117), Kitchener, Ontario
Stronach Regional Cancer Centre ( Site 0101), Newmarket, Ontario
Health Sciences North Research Institute ( Site 0115), Sudbury, Ontario
CISSS de la Monteregie-Centre ( Site 0114), Greenfield Park, Quebec
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0105), Montreal, Quebec
CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0110), Montreal, Quebec
Centre de Sante et des Services Sociaux de Rimouski-Neigette ( Site 0104), Rimouski, Quebec
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0103), Sherbrooke, Quebec
Fundacion Colombiana de Cancerologia Clinica Vida ( Site 0604), Medellin, Antioquia
Clinica de la Costa S.A.S. ( Site 0608), Barranquilla, Atlantico
Administradora Country S.A. ( Site 0603), Bogota, Distrito Capital De Bogota
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 0601), Bogotá, Distrito Capital De Bogota
Institut De Cancerologie De Lorraine ( Site 1409), Vandoeuvre les Nancy, Ain
Centre Hospitalier De Chauny ( Site 1411), Chauny, Aisne
CHU Caen ( Site 1406), Caen, Calvados
CHU Angers ( Site 1405), Angers, Maine-et-Loire
Hopital Robert Schuman ( Site 1402), Vantoux, Moselle
Centre Jean Perrin ( Site 1407), Clermont Ferrand, Puy-de-Dome
Centre Hospitalier de Pau ( Site 1412), Pau, Pyrenees-Atlantiques
CHU de Rouen ( Site 1403), Rouen, Seine-Maritime
Hopital d'Instruction des Armees Begin ( Site 1413), Saint-Mande, Val-de-Marne
Studienzentrum Aschaffenburg ( Site 1525), Aschaffenburg, Bayern
Klinikum Bogenhausen Staedt. Klinikum Muenchen GmbH ( Site 1523), Muenchen, Bayern
Klinikum der LMU ( Site 1500), Munich, Bayern
Universitaetsklinikum Regensburg ( Site 1512), Regensburg, Bayern
Klinikum Wuerzburg Mitte gGmbH ( Site 1509), Wuerzburg, Bayern
Universitaetsklinikum Frankfurt ( Site 1513), Frankfurt, Hessen
Pneumologische Lehrklinik Universitaet Goettingen ( Site 1501), Immenhausen, Hessen
Universitaetsmedizin Goettingen ( Site 1507), Goettingen, Niedersachsen
Universitaetsklinikum Bonn ( Site 1524), Bonn, Nordrhein-Westfalen
Kliniken Essen Mitte ( Site 1517), Essen, Nordrhein-Westfalen
InVo-Institut fuer Versorgungsforschung in der Onkologie ( Site 1514), Koblenz, Rheinland-Pfalz
Helios Klinikum Erfurt GmbH ( Site 1502), Erfurt, Thuringen
Katholisches Marienkrankenhaus gGmbH ( Site 1522), Hamburg, Not set
National Hospital Organization Nagoya Medical Center ( Site 0806), Nagoya, Aichi
Aichi Cancer Center ( Site 0803), Nagoya, Aichi
National Cancer Center Hospital East ( Site 0801), Kashiwa, Chiba
Kanazawa University Hospital ( Site 0811), Kanazawa, Ishikawa
Kanagawa Cancer Center ( Site 0807), Yokohama, Kanagawa
Sendai Kousei Hospital ( Site 0812), Sendai, Miyagi
Kansai Medical University Hospital ( Site 0804), Hirakata, Osaka
National Hospital Organization Kinki-chuo Chest Medical Center ( Site 0813), Sakai, Osaka
Shizuoka Cancer Center ( Site 0802), Suntogun, Shizuoka
National Hospital Organization Kyushu Medical Center ( Site 0805), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 0808), Niigata, Not set
Okayama University Hospital ( Site 0810), Okayama, Not set
Osaka International Cancer Institute ( Site 0809), Osaka, Not set
Cancer Institute Hospital of JFCR ( Site 0800), Tokyo, Not set
Chungbuk National University Hospital ( Site 1002), Cheongju si, Chungbuk
National Cancer Center ( Site 1006), Goyang-si, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 1003), Suwon, Kyonggi-do
Ajou University Hospital ( Site 1004), Suwon, Kyonggi-do
Gyeongsang National University Hospital ( Site 1005), Jinju, Kyongsangnam-do
Asan Medical Center ( Site 1007), Songpa-gu, Seoul
Seoul National University Hospital ( Site 1000), Seoul, Not set
Korea University Guro Hospital ( Site 1008), Seoul, Not set
MidCentral DHB Palmerston North Hospital ( Site 1102), Palmerston North, Manawatu-Wanganui
Capital & Coast District Health Board - Wellington Hospital ( Site 1101), Wellington, Not set
Wielospecjalistyczny Szpital SPZOZ w Zgorzelcu ( Site 2404), Zgorzelec, Dolnoslaskie
Krakowski Szpital Specjalistyczny im Jana Pawla II ( Site 2420), Krakow, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 2418), Warszawa, Mazowieckie
Szpital Rejonowy im. dr Jozefa Rostka ( Site 2402), Raciborz, Slaskie
Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 2417), Olsztyn, Warminsko-mazurskie
Przychodnia Lekarska Komed ( Site 2416), Konin, Wielkopolskie
MED-POLONIA Sp. z o.o. ( Site 2419), Poznan, Wielkopolskie
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L. ( Site 2502), Bucharest, Bucuresti
Cardiomed SRL Cluj-Napoca ( Site 2504), Cluj Napoca, Cluj
S.C. Radiotherapy Center Cluj S.R.L ( Site 2507), Cluj-Napoca, Cluj
Ovidius Clinical Hospital OCH ( Site 2501), Ovidiu, Constanta
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2508), Craiova, Dolj
Policlinica Oncomed SRL ( Site 2505), Timisoara, Timis
Spitalul PDR Medlife ( Site 2509), Brasov, Not set
Moscow Regional Oncological Dispensary ( Site 2028), Balashikha, Moskovskaya Oblast
Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 2000), Moscow, Moskva
First Moscow State Medical University n.a. I.M.Sechenov ( Site 2024), Moscow, Moskva
Moscow Research Oncology Institute named after P.A. Hertsen ( Site 2009), Moscow, Moskva
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 2006), Moscow, Moskva
Nizhniy Novgorod Region Oncology Dispensary ( Site 2026), Nizhniy Novgorod, Nizhegorodskaya Oblast
Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary-Chemotherapy #1 ( Site 2010), Omsk, Omskaya Oblast
SBHI Samara Regional Clinical Oncology Dispensary ( Site 2016), Samara, Samarskaya Oblast
SBHI Leningrad Regional Clinical Hospital ( Site 2002), Saint Petersburg, Sankt-Peterburg
SPb Central Clinical Railway Hospital ( Site 2003), Saint Petersburg, Sankt-Peterburg
National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 2004), Saint Petersburg, Sankt-Peterburg
SPb SBHI City Clinical Oncological Dispensary ( Site 2001), Saint Petersburg, Sankt-Peterburg
Republican Clinical Oncology Dispensary of Tatarstan MoH named after professor M.Z. Sigal ( Site 2021), Kazan, Tatarstan, Respublika
Hospital Universitario Quiron Madrid ( Site 1701), Pozuelo de Alarcon, Madrid
Hospital Clinico Universitario de Valencia ( Site 1706), Valencia, Valenciana, Comunitat
Hospital del Mar ( Site 1702), Barcelona, Not set
Hospital Universitario Nuestra Senora de Valme ( Site 1703), Sevilla, Not set
Hospital Clinico Lozano Blesa ( Site 1700), Zaragoza, Not set
Chang Gung Medical Foundation. Kaohsiung Branch ( Site 0907), Kaohsiung, Not set
China Medical University Hospital ( Site 0904), Taichung, Not set
National Cheng Kung University Hospital ( Site 0905), Tainan, Not set
National Taiwan University Hospital ( Site 0900), Taipei, Not set
Mackay Memorial Hospital ( Site 0902), Taipei, Not set
Chang Gung Medical Foundation.Linkou Branch ( Site 0903), Taoyuan, Not set
Namik Kemal Universitesi Tip Fakultesi ( Site 2100), Tekirdag, Tekirdas
Baskent Unv. Adana Uyg. ve Arast. Hastanesi ( Site 2101), Adana, Not set
Gazi Universitesi Tip Fakultesi ( Site 2104), Ankara, Not set
Ankara Bilkent Sehir Hastanesi ( Site 2105), Ankara, Not set
Bezmialem Vakif Univ. Tıp Fakultesi Hastanesi Tibbi Onkoloji Bolumu ( Site 2107), Istanbul, Not set
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2103), Istanbul, Not set
Ege Universitesi Tip Fakultesi ( Site 2109), Izmir, Not set
Erciyes Universitesi Tip Fakultesi ( Site 2108), Kayseri, Not set
Ondokuz Mayıs Universitesi-Oncology department ( Site 2106), Samsun, Not set
Cherkasy Regional Oncology Dispensary ( Site 2211), Cherkasy, Cherkaska Oblast
Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council ( Site 2201), Dnipro, Dnipropetrovska Oblast
MI Precarpathian Clinical Oncology Center ( Site 2204), Ivano-Frankivsk, Ivano-Frankivska Oblast
Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2212), Kharkiv, Kharkivska Oblast
CNPE "Regional Center of Oncology"-Thoracic organs ( Site 2205), Kharkiv, Kharkivska Oblast
PP PPC Acinus Medical and Diagnostic Centre ( Site 2209), Kropyvnitskiy, Kirovohradska Oblast
Medical Center Asklepion LLC ( Site 2234), Khodosivka, Kyivska Oblast
Medical Center Verum ( Site 2230), Kyiv, Kyivska Oblast
Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 2213), Kyiv, Kyivska Oblast
MI Odessa Regional Oncological Centre ( Site 2208), Odesa, Odeska Oblast
Central City Clinical Hospital ( Site 2207), Uzhgorod, Zakarpatska Oblast
Kyiv City Clinical Oncology Centre ( Site 2210), Kyiv, Not set
Barts Health NHS Trust - St Bartholomew s Hospital ( Site 1923), London, London, City Of
Chelsea and Westminster Hospital ( Site 1901), London, London, City Of
West Suffolk Hospitals NHS Trust ( Site 1919), Bury Saint Edmunds, Suffolk
Singleton Hospital ( Site 1909), Swansea, Wales
Colchester General Hospital ( Site 1911), Colchester, Worcestershire
Birmingham Heartlands Hospital ( Site 1910), Birmingham, Not set
Western General Hospital, Edinburgh ( Site 1924), Edinburg, Not set
Conditions: Carcinoma, Nonsquamous Non-small-cell Lung
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Active Not Recruiting
This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy.
The patients in this study will have advanced human epidermal growth factor 2 (HER2)-positive stomach and esophageal cancers that are no longer treatable with surgery (unresectable) or chemoradiation, and/or have grown or spread to other parts of the body (metastatic).
This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy.
The patients in this study will have advanced human epidermal growth factor 2 (HER2)-positive stomach and esophageal cancers that are no longer treatable with surgery (unresectable) or chemoradiation, and/or have grown or spread to other parts of the body (metastatic). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2025
Locations: Hospital de Gastroenterología Dr Bonorino Udaondo, Buenos Aires, Not set +225 locations
Hospital de Gastroenterología Dr Bonorino Udaondo, Buenos Aires, Not set
Hospital Italiano de Buenos Aires, Buenos Aires, Not set
Instituto de Investigaciones Metabólicas - IDIM, Ciudad Autónoma de Buenos Aires, Not set
Fundación Centro de Medicina Nuclear y Molecular ER, Córdoba, Not set
Centro Médico Privado CEMAIC, Córdoba, Not set
Centro de Investigación Pergamino S.A., Pergamino, Not set
Centro de Investigación Clínica - Clínica Viedma, Viedma, Not set
Flinders Medical Centre, Bedford Park, Not set
Austin Health, Heidelberg, Not set
Liverpool Hospital, Liverpool, Not set
Fiona Stanley Hospital, Murdoch, Not set
Imelda VZW, Bonheiden, Not set
Cliniques Universitaires Saint-Luc, Brussels, Not set
UZ Gent, Gent, Not set
UZ Leuven, Leuven, Not set
CHU de Liège, Liège, Not set
Centro Integrado de Pesquisa - CIP, Barretos, Not set
Fundação Pio XII Hospital de Câncer de Barretos, Barretos, Not set
Cenantron - Centro Avancado de Tratamento Oncologico Ltda, Belo Horizonte, Not set
Centro de Pesquisas Clínicas/Fundação Doutor Amaral Carvalho, Brasília, Not set
Instituto Do Câncer Do Ceará ICC, Fortaleza, Not set
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre, Not set
Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Not set
Hospital Nossa Senhora Da Conceição, Porto Alegre, Not set
Núcleo de Pesquisa Clínica da Rede São Camilo, Santo André, Not set
Instituto de Oncologia de Sorocaba, Sorocaba, Not set
Instituto do Cancer do Estado de São Paulo ICESP, São Paulo, Not set
Princess Margaret Cancer Centre, Toronto, Not set
Centro Internacional de Estudios Clinicos CIEC, Santiago, Region Metropolitan
Fundación Arturo López Pérez (FALP) - PPDS, Providencia, Región-Metropolitana De Santiago
Centro de Estudios Clínicos SAGA SpA, Providencia, Not set
Sociedad Oncovida S.A, Santiago, Not set
Icegclinic, Santiago, Not set
BIOCINETIC SpA, Santiago, Not set
Sociedad de Investigaciones Medicas Limitada, Temuco, Not set
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Not set
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
Peking University Third Hospital, Beijing, Not set
Beijing Luhe Hospital, Capital Medical University, Beijing, Not set
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Not set
Hunan Cancer Hospital, Changsha, Not set
Changzhi People's Hospital, Changzhi, Not set
Changzhou First People's Hospital, Changzhou, Not set
Sichuan Cancer Hospital & Institute, Chengdu, Not set
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Not set
Fujian Cancer Hospital, Fuzhou, Not set
Guangdong Provincial People's Hospital, Guangzhou, Not set
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Not set
Hainan General Hospital, Haikou, Not set
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Not set
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Not set
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Harbin Medical University Cancer Hospital, Harbin, Not set
Anhui Provincial Cancer Hospital, Hefei, Not set
The Second Affiliated Hospital of Anhui Medical University, Hefei, Not set
Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Not set
Shandong Cancer Hospital, Jinan, Not set
Jinan Central Hospital, Jinan, Not set
Yunnan Cancer Hospital, Kunming, Not set
The First Hospital of Lanzhou University, Lanzhou, Not set
Gansu Cancer Hospital, Lanzhou, Not set
The First Affiliated Hospital of Nanchang University, Nanchang, Not set
Nanjing Drum Tower Hospital ,The Affiliated Hospital of Nanjing University Medical School, Nanjing, Not set
The Affiliated Hospital of Qingdao University, Qingdao, Not set
Ruijin hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Not set
Fudan University Affiliated Zhongshan Hospital, Shanghai, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
Shanghai General Hospital, Shanghai, Not set
Liaoning Cancer Hospital & Institute, Shenyang, Not set
The Fourth Hospital of Hebei Medical University, Shijiazhuang, Not set
Tianjin Medical University General Hospital, Tianjin, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
The Tonghua Central Hospital, Tonghua, Not set
Weihai Municipal Hospital, Weihai, Not set
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set
Union Hospital Tongji Medical College HuaZhong University of Science and Technology, Wuhan, Not set
Hubei Cancer Hospital, Wuhan, Not set
Affiliated Hospital of Jiangnan University, Wuxi, Not set
First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Not set
The First Affiliated Hospital of Xiamen University, Xiamen, Not set
Northern Jiangsu People's Hospital, Yangzhou, Not set
Henan Cancer Hospital, Zhengzhou, Not set
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Not set
Cancer Hospital affiliated to Xinjiang Medical University, Ürümqi, Not set
North Estonia Medical Centre Foundation, Tallinn, Not set
CHU de Bordeaux - Hopital Haut Leveque, Pessac, Gironde
Sainte-Catherine, Institut du Cancer Avignon Provence, Avignon, Not set
EDOG - Institut Bergonie - PPDS, Bordeaux, Not set
Universite de Bourgogne - Faculte de Medecine - IN, Dijon, Not set
Centre Hospitalier Universitaire Grenoble Alpes - Hopital Albert Michallon, Grenoble, Not set
Centre Léon Berard, Lyon, Not set
EDOG Institut de Cancerologie de l'Ouest - PPDS, Nantes, Not set
CHRU de Poitiers La Miletrie, Poitiers, Not set
EDOG - Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer - PPDS, Rennes, Not set
CHRU de Brest - Hopital Morvan, Saint-Priest-en-Jarez, Not set
Hôpital de Rangueil, Toulouse, Not set
Hôpital Saint Antoine, Villejuif, Not set
Research Institute of Clinical Medicine, Tbilisi, Not set
High Technology Hospital MedCenter Ltd, Tbilisi, Not set
Institut für Klinisch-Onkologische Forschung, Frankfurt am Main, Hessen
Attikon University General Hospital, Athens, Not set
Bioclinic Thessaloniki Oncology Department, Thessaloniki, Not set
Agios Loucas Clinic SA, Thessaloniki, Not set
Interbalkan Medical Center of Thessaloniki Oncology Department, Thessaloniki, Not set
Clinica Medica Especializada CELAN, Guatemala City, Not set
Grupo Medico Angeles, Guatemala City, Not set
Centro Medico Integral de Cancerologia CEMIC, Salcaja, Not set
All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, Not set
Artemis Hospital, Gurgaon, Not set
MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad, Not set
Indraprastha Apollo Hospitals, New Delhi, Not set
Regional Cancer Centre Indira Gandhi Institute of Medical Sciences, Patna, Not set
HCG City Cancer Center, Vijayawada, Not set
St James's Hospital, Dublin, Not set
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna, Not set
Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo, Not set
Ospedale Policlinico San Martino, Genova, Not set
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS, Meldola, Not set
Ospedale San Raffaele S.r.l. - PPDS, Milano, Not set
Istituto Nazionale Dei Tumori, Milano, Not set
ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda, Milano, Not set
Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Not set
Arcispedale Santa Maria Nuova, Reggio Emilia, Not set
Fondazione Policlinico Universitario A Gemelli, Rome, Not set
Centro Ricerche Cliniche Di Verona, Verona, Not set
Azienda ULSS 8 "Berica" - Ospedale San Bortolo, Vicenza, Not set
Gifu University Hospital, Gifu-Shi, Gihu
Gunma Prefectural Cancer Center, Ota-shi, Gunma
Hyogo Cancer Center, Akashi-shi, Hyôgo
Ibaraki Prefectural Central Hospital, Kasama-Shi, Ibaraki
Kagawa University Hospital, Kita-Gun Miki-Cho, Kagawa
Kanagawa Cancer Center, Yokohama-Shi Asahi-Ku, Kanagawa
Kumamoto University Hospital - Honjo-Kuhonji Campus A, Chuo-Ku, Kumamoto
Kyoto University Hospital, Sakyo-ku, Kyoto-shi
Osaki Citizen Hospital, Osaki-Shi, Miyagi
Kurashiki Central Hospital, Kurashiki-Shi, Okayama
Osaka University Hospital, Suita-Shi, Osaka
Osaka Medical and Pharmaceutical University Hospital, Takatsuki-Shi, Osaka
Chiba Cancer Center, Chiba-Shi, Tiba
National Cancer Center Hospital East, Kashiwa-shi, Tiba
Keio University Hospital, Shinjuku-Ku, Tokyo
National Cancer Center Hospital, Chuo Ku, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka-shi, Not set
Saitama Cancer Center, Ina, Not set
Shikoku Cancer Center, Matsuyama, Not set
Kindai University Hospital, Osaka-sayama, Not set
Osaka International Cancer Institute, Osaka, Not set
The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Tokyo, Not set
Hallym University Sacred Heart Hospital, Anyang-si, Not set
Dong-A University Hospital, Busan, Not set
Kyungpook National University Chilgok Hospital, Daegu, Not set
National Cancer Center, Goyang-si, Not set
Gachon University Gil Medical Center, Incheon, Not set
CHA Bundang Medical Center, CHA University, Seongnam-si, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set
Kangbuk Samsung Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System - PPDS, Seoul, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Yonsei University Health System, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
Hospital Pulau Pinang, George Town, Not set
Sarawak General Hospital, Kuching, Not set
National Cancer Institute ( Institut Kanser Negara), Putrajaya, Not set
Health Pharma Professional Research S.A de C.V., Mexico City, Not set
Hospital Universitario Dr. Jose Eleuterio González, Monterrey, Not set
Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set
Catharina Hospital, Eindhoven, Not set
Leids Universitair Medisch Centrum, Leiden, Not set
ETZ-Elisabeth, Tilburg, Not set
Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Warszawa, Not set
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Łódź, Not set
Hospital Garcia de Orta, Almada, Not set
Centro Hospitalar E Universitário de Coimbra EPE, Coimbra, Not set
Hospital Senhora da Oliveira - Guimaraes, E.P.E, Guimarães, Not set
Centro Hospitalar Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisboa, Not set
Unidade Local de Saúde de Matosinhos SA, Matosinhos, Not set
Centro Hospitalar do Porto EPE, Porto, Not set
Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto, Not set
Fundeni Clinical Institute, București, Not set
Prof Dr I Chiricuta Institute of Oncology - PPDS, Cluj-Napoca, Not set
Medisprof SRL, Cluj-Napoca, Not set
Oncology Center Sfantul Nectarie, Craiova, Not set
University Clinical Center of Serbia - PPDS, Belgrade, Not set
Clinical Hospital Center Bezanijska Kosa, Belgrade, Not set
University Clinical Center Nis, Niš, Not set
Oncology Institute of Vojvodina, Sremska Kamenica, Not set
National Cancer Center Singapore, Singapore, Not set
Wilgers Oncology Centre, Pretoria, Not set
Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona
Complejo Hospitalario de Navarra, Pamplona, Navarra
Hospital Universitario Germans Trias i Pujol, Badalona, Not set
Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Not set
Hospital Universitari de Girona Dr Josep Trueta, Girona, Not set
Institut Català d'Oncologia (Hospital Duran y Reynals), L'Hospitalet de Llobregat, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
Hospital Universitario La Paz - PPDS, Madrid, Not set
Hospital Regional Universitario de Malaga - Hospital General, Málaga, Not set
Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Not set
Hospital Universitario Marques de Valdecilla, Santander, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
China Medical University Hospital, Taichung, Not set
Taipei Veterans General Hospital, Taipei, Not set
Songklanagarind Hospital, Hat Yai, Not set
Srinagarind Hospital, Khon Kaen University, Khon Kaen, Not set
Hacettepe Universitesi Kanser Enstitusu, Ankara, Not set
Trakya University Medical Faculty, Edirne, Not set
Dokuz Eylul Universitesi, Izmir, Not set
Acibadem Adana Hospital, Seyhan, Not set
Medical Park Trabzon Yildizli, Trabzon, Not set
Dr. Abdurrahman Yurtaslan Ankara Onkology Training and Research Hospital, Yenimahalle, Not set
The Municipal Enterprise Volyn Regional Medical Oncology Centre of the Volyn Regional Council, Lutsk, Not set
Bristol Haematology and Oncology Centre, Bristol, Not set
Western General Hospital Edinburgh - PPDS, Edinburgh, Not set
St James University Hospital, Leeds, Not set
Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London, Not set
Royal Marsden Hospital - London, London, Not set
Royal Marsden Hospital - Surrey, London, Not set
Edith Cavell Hospital, Peterborough, Not set
Weston Park Cancer Centre, Sheffield, Not set
Conditions: Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Completed
The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC).
The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/28/2025
Locations: Smilow Cancer Hospital At Yale, New Haven, Connecticut +123 locations
Smilow Cancer Hospital At Yale, New Haven, Connecticut
Renovatio Clinical, The Woodlands, Texas
Coffs Harbour Base Hospital, Coffs Harbour, New South Wales
St Vincents Hospital Melbourne, Fitzroy, Victoria
Institut Jules Bordet, Anderlecht, Not set
Az Sint Jan Brugge, Brugge, Not set
Grand Hopital de Charleroi Site Notre Dame, Charleroi, Not set
UZ GENT, Gand, Not set
University Hospitals Leuven, Leuven, Not set
Chc Montlegia, Liege, Not set
Anhui Provincial Hospital, Hefei, Anhui
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei, Anhui
The Second Hospital of Anhui Medical University, Hefei, Anhui
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing
The Fifth Medical Center of Chinese Pla General Hospital, Beijing, Beijing
Beijing Cancer Hospital, Beijing, Beijing
Peking Union Medical College Hospital, Beijing, Beijing
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian
Fujian Cancer Hospital, Fuzhou, Fujian
Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou, Fujian
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian
Zhongshan Hospital Xiamen University, Xiamen, Fujian
The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong
Guangdong Province Traditional Chinese Medical Hospitsal, Guangzhou, Guangdong
The Sixth Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
The Tumor Hospital Affiliated to Guangxi Medical University, Nanning, Guangxi
Hainan General Hospital, Haikou, Hainan
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan
Henan Cancer Hospital, Zhengzhou, Henan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
Hubei Cancer Hospital, Wuhan, Hubei
Xiangyang Central Hospital, Xiangyang, Hubei
Hunan Cancer Hospital, Changsha, Hunan
The First Peoples Hospital of Changzhou, Changzhou, Jiangsu
Jiangsu Province Hospital, Nanjing, Jiangsu
Nantong Tumor Hospital Branch North, Nantong, Jiangsu
Affiliated Hospital of Jiangnan University North Campus (Wuxi Fourth Peoples Hospital ), Wuxi, Jiangsu
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning
Shandong Cancer Hospital, Jinan, Shandong
Linyi Cancer Hospital, Linyi, Shandong
Weifang Peoples Hospital, Weifang, Shandong
Fudan University Shanghai Cancer Center, Shanghai, Shanghai
Shanxi Provincial Peoples Hospital, Taiyuan, Shanxi
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Fakultni Thomayerova Nemocnice, Praha, Not set
Chru de Brest Hopital Cavale Blanche, Brest, Not set
Chu Besancon Hopital Jean Minjoz, Doubs, Not set
Hopital Franco Britannique, LevalloisPerret, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon Cedex, Not set
Hopital Saint Antoine Service Dhepato Gastro Enterologie, Paris Cedex, Not set
Hopital Europeen Georges Pompidou, Paris, Not set
Chu Bordeaux Hopital Haut Leveque, Pessac, Not set
Chu de Poitiers Site de La Mileterie, Poitiers, Not set
Centre de Lutte Contre Le Cancer Institut de Cancerologie de Louest Rene Gauducheau, SaintHerblain, Not set
Universitatsklinikum Hamburg Eppendorf, Hamburg, Not set
Slk Kliniken Heilbronn Gmbh Klinik Fur Radiologie, Minimalinvasive Therapien Und Nuklearmedizin, Heilbronn, Not set
Universitares Krebszentrum Leipzig, Leipzig, Not set
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola, Not set
Istituto Europeo Di Oncologia, Milano, Not set
Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Not set
Iov Istituto Oncologico Veneto Irccs, Padova, Not set
Azienda Ospedaliera Universitaria Delle Marche, Torrette, Not set
Akita University Hospital, Akitashi, Akita
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Kyushu Medical Center, Fukuokacity, Fukuoka
Nho Kyushu Cancer Center, FukuokaShi, Fukuoka
Hyogo Cancer Center, AkashiShi, Hyogo
Johas Kansai Rosai Hospital, Amagasakishi, Hyogo
Kanagawa Cancer Center, Yokohamashi, Kanagawa
University Hospital, Kyoto Prefectural Univ of Medicine, KyotoShi, Kyoto
Osaka International Cancer Institute, OsakaShi, Osaka
The University of Osaka Hospital, Suitashi, Osaka
Saitama Cancer Center, Kitaadachigun, Saitama
National Cancer Center Hospital, ChuoKu, Tokyo
Hiroshima University Hospital, Hiroshima, Not set
Kumamoto University Hospital, Kumamoto, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Keimyung University Dongsan Hospital, Dalseogu, Daegu Gwang'yeogsi
Cha Bundang Medical Center, Cha University, BundangGu SeongnamSi, Gyeonggi-do
Seoul National University Bundang Hospital, BundangGu SeongnamSi, Gyeonggi-do
Gachon University Gil Medical Center, NamdongGu, Incheon Gwang'yeogsi
Chonnam National University Hwasun Hospital, HwasunGun, Jeollanam-do
Smg Snu Boramae Medical Center, DongjakGu, Seoul Teugbyeolsi
Korea University Guro Hospital, GuroGu, Seoul Teugbyeolsi
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi
Samsung Medical Center Hematology Oncology, Seoul, Seoul Teugbyeolsi
Asan Medical Center, SongpaGu, Seoul Teugbyeolsi
Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozow, Not set
Szpital Wojewodzki Im Mikoaja Kopernika W Koszalinie, Koszalin, Not set
Spzoz Mswia Z Warminsko Mazurskim Centrum Onkologii, Olsztyn, Not set
Narodowy Instytut Onkologii Im Marii Skodowskiej Curie Pastwowy Instytut Badawczy, Warszawa, Not set
Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca, Not set
Medisprof Cancer Center, ClujNapoca, Not set
Radiotherapy Center Cluj, ClujNapoca, Not set
Sc Centrul de Oncologie Sf Nectarie Srl, Craiova, Not set
Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk, Arkhangel'skaya Oblast'
Rbih Ivanovo Regional Oncological Dispensary, Ivanovo, Ivanovskaya Oblast'
State Budget Healthcare Institution Leningrad Regional Clinical Oncologic Dispensary, Kuzmolovsky, Leningradskaya Oblast'
Orenburg Regional Clinical Oncology Center, Orenburg, Orenburgskaya Oblast'
Rostov State Medical University, RostovonDon, Rostovskaya Oblast'
Pavlov First Saint Petersburg State Medical University, SaintPetersburg, Sankt-Peterburg
Fsbi National Medical Research Center For Oncology Na Nn Petrov of the Moh of the Rf, SaintPetersburg, Not set
Hospital Universitario Vall Dhebron, Barcelona, Not set
Institut Catala Doncologia, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Hospital Regional Universitario de Malaga, Malaga, Not set
Hospital Universitario Central de Asturias, Oviedo, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
Chiayi Chang Gung Memorial Hospital, Chiayi, Not set
Chi Mei Hospital Liouying, Liuying Dist, Not set
China Medical University Hospital, North Dist, Not set
Chi Mei Medical Center, Yongkang Dist, Not set
The Christie Hospital, Greater Manchester, Not set
Guys and St Thomas Hospital Nhs Foundation Trust, London, Not set
Conditions: Esophageal Squamous Cell Carcinoma (ESCC)
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Recruiting
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building... Read More
Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor receptor 2 (HER2) mutations.
Advanced NSCLC is a group of lung cancers that have spread to nearby tissues or to other parts of the body or that are unlikely to be cured or controlled with currently available treatments. HER2 is a protein that helps cells to grow and divide. A damage (also called mutation) to the building plans (genes) for this protein in cancer cells leads to a production of abnormal HER2 and therefore abnormal cell growth and division.
The study treatment, BAY 2927088, is expected to block the mutated HER2 protein which may stop the spread of NSCLC.
The main purpose of this study is to learn how well BAY 2927088 works and how safe it is compared with standard treatment, in participants who have advanced NSCLC with specific genetic changes called HER2 mutations.
The study participants will receive one of the study treatments:
* BAY 2927088 twice every day as a tablet by mouth, or
* Standard treatment in cycles of 21 days via infusion ("drip") into the vein. The treatment will continue for as long as participants benefit from it without any severe side effects or until they or their doctor decide to stop the treatment.
During the study, the doctors and their study team will:
* take imaging scans, including CT, PET, MRI, and X-rays, of different parts of the body to study the spread of cancer
* check the overall health of the participants by performing tests such as blood and urine tests, and checking
* heart health using an electrocardiogram (ECG)
* perform pregnancy tests for women
* ask the participants questions about how they are feeling and what adverse events they are having.
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Patty & George Hoag Cancer Center, Newport Beach, California +278 locations
Patty & George Hoag Cancer Center, Newport Beach, California
UC San Diego Health - Moores Cancer Center, San Diego, California
UCSF Bakar Precision Cancer Medicine Building - Thoracic Surgery and Oncology, San Francisco, California
UCLA Health Santa Monica Cancer Care, Santa Monica, California
The Oncology Institute of Hope and Innovation - Fort Lauderdale 17th Street, Fort Lauderdale, Florida
Memorial Cancer Institute at Miramar, Miramar, Florida
AdventHealth Cancer Institute, Orlando, Florida
Moffitt Cancer Center - Magnolia Campus, Tampa, Florida
Moffitt Cancer Center, Tampa, Florida
Piedmont Cancer Institute - Atlanta, Atlanta, Georgia
John B. Amos Cancer Center, Columbus, Georgia
University of Illinois Hospital - Outpatient Cancer Care Center, Chicago, Illinois
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology, Chicago, Illinois
UM Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
UMass Memorial Medical Center - University Campus - Oncology, Worcester, Massachusetts
Profound Research -OMG - TriAtria Cancer Center, Farmington Hills, Michigan
Profound Research - OMG - Royal Oak Cancer Center, Royal Oak, Michigan
University of Minnesota Medical Center, Minneapolis, Minnesota
R.J. Zuckerberg Cancer Center, New Hyde Park, New York
UC Medical Center - Oncology, Cincinnati, Ohio
Providence Cancer Institute - Franz Clinic, Portland, Oregon
Providence Oncology and Hematology Care Clinic Westside, Portland, Oregon
Allegheny General Hospital, Pittsburgh, Pennsylvania
UT Southwestern, Dallas, Texas
University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston, Texas
Virginia Commonwealth University, Richmond, Virginia
Fundación Cenit para la Investigación en Neurociencias, Caba, Ciudad Auton. De Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires, Not set
Centro de Educacion Medica e Investigaciones Clinicas "Norberto Quirno" (CEMIC), Buenos Aires, Not set
Centro Médico Privado CEMAIC, Córdoba, Not set
Instituto Argentino de Diagnostico y Tratamiento (IADT), TBC, Not set
Centro de Investigaciones Clínicas, Clínica Viedma, Viedma, Not set
Blacktown Cancer & Haematology Centre, Blacktown, New South Wales
Concord Repatriation General Hospital - Medical Oncology Clinical Trials Unit, Concord, New South Wales
Calvary Mater Hospital Newcastle, Waratah, New South Wales
University of the Sunshine Coast, Buderim, Not set
The Canberra Hospital (TCH) - Canberra Region Cancer Centre (CRCC), Garran, Not set
Austin Hospital - Olivia Newton John Cancer Research Institute, Heidelberg, Not set
Uniklinikum Salzburg, Universitätsklinik für Innere Medizin III, Salzburg, Not set
Uniklinikum Salzburg, Universitätsklinik für Pneumologie/ Lungenheilkunde, Salzburg, Not set
Medizinische Universität Wien Universitätsklinik f. Innere Medizin I Klinische Abteilung für Onkologie, Wien, Not set
Klinik Floridsdorf, Pneumo-onkologische Ambulanz und Tagesklinik, Wien, Not set
UZ Leuven Gasthuisberg - Pneumology Department, Leuven, Vlaams-Brabant
AZ Delta | Clinical Trial Center - Pneumology, Roeselare, West-Flanders
Antwerp University Hospital | Oncology Department, Antwerpen, Not set
Rede DoR Recife - PE, Recife, Pernambuco
Liga Norte Riograndense Contra o Cancer | Centro de Pesquisa Clínica, Natal, Rio Grande Do Norte
Irmandade Santa Casa de Misericordia de Porto Alegre | Oncology, Porto Alegre, Rio Grande Do Sul
Centro de Pesquisa da Clínica de Oncologia Reichow, Blumenau, Santa Catarina
Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos, Sao Paulo
Hospital de Base | Integrated Research Center, São José do Rio Preto, Sao Paulo
NAIC - Instituto do Cancer, Bauru, Not set
Hospital Sirio-Libanes (HSL) - Centro de Oncologia - Brasilia, Brasilia, Not set
Pronutrir Fortaleza - CE, Fortaleza, Not set
Hospital Sirio Libanes, Sao Paulo, Not set
A Beneficencia Portuguesa de Sao Paulo - Hospital BP Mirante, Sao Paulo, Not set
Centro Paulista de Oncologia (CPO) - Sao Paulo - Faria Lima, Sao Paulo, Not set
MHAT Uni Hospital, Panagyurishte, Pazardzhik
MHAT "Heart and brain" Pleven, Pleven, Not set
Complex Oncology Center - Plovdiv EOOD, Plovdiv, Not set
MHAT Park Hospital EOOD, Plovdiv, Not set
Multiprofile Hospital for Active Treatment "Sveta Sofia", Sofia, Not set
MHAT Serdika, Sofia, Not set
Specialized Hospital for Active Treatment of Oncology, Sofia, Not set
University Multiprofile Hospital For Active Treatment Sofiamed OOD, Sofia, Sofia, Not set
MHAT Sveta Marina EAD, Varna, Not set
BC Cancer - Vancouver Site, Vancouver, British Columbia
Brampton Civic Hospital - Oncology, Brampton, Ontario
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto, Ontario
Jewish General Hospital - Department of Pulmonary Oncology, Montreal, Quebec
Beijing Cancer Hospital - Oncology Department, Beijing, Beijing
Beijing Hospital, Beijing, Beijing
Fujian Cancer Hospital, Fuzhou, Fujian
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Union Hospi, Tongji Med College, Huazhong Univ. Scien&Tech, Wuhan, Hubei
Hubei Cancer Hospital, Wuhan, Hubei
Hunan Cancer Hospital - Oncology Department, Changsha, Hunan
NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu
Jilin Cancer Hospital, Changchun, Jilin
Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, Shanghai
West China Hospital Sichuan University, Chengdu, Sichuan
Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Zhejiang University School of Medicine - Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Not set
The People's Liberation Army General Hospital (Beijing 301 Hospital), Beijing, Not set
Beijing chest hospital, Capital Medical University, Beijing, Not set
University of Electronic Science & Technology of China - Sichuan Cancer Hospital & Institute (Sichuan Provincial Tumor Hospital), Chengdu, Not set
Guangzhou Medical University - The First Affiliated Hospital, Guangzhou, Not set
Shandong University - Shandong Cancer Hospital, Jinan, Not set
LinYi Cancer Hospital (Linyi Tumor Hospital), Linyi, Not set
Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University, Nanjing, Not set
Guangxi Medical University (GXMU) - Affiliated Tumor Hospital, Nanning, Not set
Zhongshan Hospital, Fudan University - Oncology Department, Shanghai, Not set
Xiamen University - The First Affiliated Hospital, Xiamen, Not set
Krajská nemocnice T. Bati - Pneumoonkologická a klinická onkologie, Zlin, Zlinsky Kraj
Masarykova Univerzita - Masarykuv Onkologicky Ustav (MOU) - Klinika Komplexni Onkologicke Pece (KKOP), Brno, Not set
Nemocnice AGEL Nový Jicín a.s. - Oddelení radioterapie a onkologie, Nový Jicín, Not set
Fakultní Nemocnice Olomouc - Klinika plicních nemocí a tuberkulózy, Olomouc, Not set
Nemocnice AGEL Ostrava-Vítkovice a. s. - Plicní oddelení, Ostrava - Vítkovice, Not set
Aalborg University hospital - oncology department, Aalborg, Not set
Aarhus Universitetshospital, Aarhus N, Not set
Rigshospitalet - Kræftbehandling, Copenhagen OE, Not set
Regionshospitalet Gødstrup - Medicinsk afdeling, Herning, Not set
Odense University Hospital - Oncology Department, Odense C, Not set
Docrates Mehiläinen Syöpäsairaala, Helsinki, Not set
Turun yliopistollinen keskussairaala, Turku, Not set
Institut Bergonie - Unicancer Nouvelle Aquitaine, Bordeaux, Not set
Hopital La Cavale Blanche - CHU de Brest - institut de cancerologie et d'imagerie, Brest, Not set
Centre Hospitalier Intercommunal Creteil - Service de pneumologie, Créteil, Not set
Centre Hospitalier Michallon Grenoble - Service pneumologie, La Tronche, Not set
Institut Coeur Poumon CHRU Lille - Pole Cardio-vasculaire et pulmonaire, Lille, Not set
Centre Hospitalier Universitaire de Limoges - unite oncologie thoracique, Limoges, Not set
CHU Montpellier - Hopital Arnaud de Villeneuve - Service oncologie thoracique, Montpellier, Not set
hopital Emile Muller - Service Pneumologie, Mulhouse, Not set
Hopital Nord Laennec - Oncologie medicale thoracique et digestive, Nantes, Not set
Centre Antoine Lacassagne - Departement Oncologie, Nice, Not set
hopital cochin APHP - service de pneumologie, Paris, Not set
Institut Curie - Paris - Oncologie medicale, Paris, Not set
hopital Lyon sud HCL - Pneumologie aigue specialisee et cancerologie thoracique, Pierre Bénite, Not set
CHU de Rouen - Hopital Charles Nicolle - Service de Pneumologie, Rouen, Not set
Institut de Cancerologie Ouest - Saint-Herblain, Saint-Herblain, Not set
Hopital Foch - Oncologie digestive et thoracique, Suresnes, Not set
Gustave Roussy - Departement Oncologie-Radiotherapie, Villejuif, Not set
Universitaetsklinikum Giessen und Marburg - Medizinische Klinik IV Organonkologie, Giessen, Hessen
Kliniken der Stadt Köln gGmbH - Krankenhaus Merheim - Lungenklinik, Köln, Nordrhein-Westfalen
Universitaetsklinikum Essen - Innere Klinik (Tumorforschung), Essen, North Rhine-Westphalia
Charité Universitätsmedizin Berlin CBF - Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Berlin, Not set
Universitätsklinikum Frankfurt - Medizinische Klinik II, Hämatologie und Onkologie, Frankfurt, Not set
Lungenklinik Hemer, Thorakale Onkologie und onkologische Palliativmedizin, Hemer, Not set
Klinikum Nürnberg - Klinik für Innere Medizin 3, Schwerpunkt Pneumologie (Lungenheilkunde), Nürnberg, Not set
Robert Bosch Krankenhaus - Haematologie, Onkologie und Palliativmedizin, Stuttgart, Not set
?enry Durant Hospital Center-4th Oncology Department and Clinical Trials Unit, Athens, Not set
University of Athens Medical School-Sotiria General Hospital - 3rd Dept of Medicine & Medical Oncology, Athens, Not set
General Hospital of Athens "Alexandra''-Plasma Cell Dyscrasias,Department of Clinical Therapeutics,School of Medicine,NKUA, Athens, Not set
University General Hospital ATTIKON, Department of Internal Medicine IV, Chaidari, Not set
University General Hospital of Athens "ATTIKON", Chaidari, Not set
University General Hospital of Larissa, Larissa, Not set
Metropolitan Hospital- 4th Oncology Clinic, Piraeus, Not set
Bioclinic Thessaloniki, Thessaloniki, Not set
PAPANIKOLAOU General Hospital of Thessaloniki, Thessaloniki, Not set
Prince of Wales Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Queen Elizabeth Hospital Hong Kong, Hong Kong, Not set
Hong Kong United Oncology Centre, Kowloon, Not set
Budapesti Uzsoki Utcai Korhaz - Tüdogyógyászati Osztály, Budapest, Not set
Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabanya, Not set
Assuta Ashdod Public Hospital (R.A), Ashdod, Not set
Soroka Medical Center- Legacy Heritage Cancer Center, Be'er Sheva, Not set
Shaare Zedek Medical Center (SZMC), Jerusalem, Not set
Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set
AORN San Giuseppe Moscati Avellino - U.O.C. Oncologia Medica, Avellino, Campania
Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - UOC Oncologia Medica, Bologna, Emilia-Romagna
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. - GDP Toracica, Meldola, Emilia-Romagna
Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati, Aviano, Friuli-Venezia Giulia
I.F.O. Istituti Fisioterapici Ospitalieri_Ospedale Regina Elena -- Oncologia Medica 2, Roma, Lazio
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOSD Oncologia Toraco-Polmonare, Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1, Milano, Lombardia
Istituto Europeo di Oncologia s.r.l - Oncologia Toracica, Milano, Lombardia
Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia, Rozzano, Lombardia
Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Oncologia Medica, Orbassano, Piemonte
Istituto Oncologico Veneto_Padova - UOC Oncologia 2, Padova, Veneto
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Careggi University Hospital - Oncologia Clinica, Firenze, Not set
Ospedale Vito Fazzi Lecce - Oncologia, Lecce, Not set
Ospedale San Raffaele s.r.l. - Oncologia Medica, Milano, Not set
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello - Oncologia Medica, Palermo, Not set
ASST Sette Laghi_Ospedale Macchi - Oncologia, Varese, Not set
Centro Ricerche Cliniche Di Verona S.r.l. - Oncologia, Verona, Not set
National Hospital Organization Nagoya Medical Center, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
Hokkaido University Hospital, Sapporo, Hokkaido
National Hospital Organization Himeji Medical Center, Himeji, Hyogo
Kobe University Hospital, Kobe, Hyogo
Kitasato University Hospital, Sagamihara, Kanagawa
Sendai Kousei Hospital, Sendai, Miyagi
Kansai Medical University Hospital, Hirakata, Osaka
Kindai University Hospital, Osakasayama, Osaka
Saitama Cancer Center, Kitaadachi-gun, Saitama
Nippon Medical School - Nippon Medical School Hospital - Cancer Center, Bunkyo-ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization-Yamaguchi-Ube Medical Center (Sanyo Hospital), Ube, Yamaguchi
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Osaka International Cancer Institute, Osaka, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbugdo
Gyeongsang National University Hospital, Jinju-si, Gyeongsangnam-do
Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnamdo
Severance Hospital, Yonsei University Health System - Oncology Department, Seoul, Seoul Teugbyeolsi
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Chonnam National University Hwasun Hospital, Hwasun Gun, Not set
Samsung Medical Center - Oncology Department, Seoul, Not set
Beacon Hospital, Petaling Jaya, Selangor
Columbia Asia Hospital Bukit Rimau, Shah Alam, Selangor
Sunway Medical Centre, Subang Jaya, Selangor
University Hospital Kebangsaan Malaysia, Cheras, Not set
Gleneagles Penang Medical Center, George Town,, Not set
University Malaya Medical Centre, Kuala Lumpur, Not set
Sunway Medical Centre Penang, Perai, Not set
Instituto Nacional de Cancerología, Mexico, Distrito Federal
Oncare Viaducto Nápoles, Cdmx, Not set
Oncología Integral Satélite, Naucalpan, Not set
Hospital Universitrio Dr. José Eleuterio González. Servicio de Oncologia, Nuevo León, Not set
Clinica Integral Internacional de Oncologia S. de R.L. de C.V., Puebla, Not set
ONCARE Treatment Center, San Pedro Garza García, Not set
Nederlands Kanker Instituut, Amsterdam, Not set
Radboud University Medical Center | Afdeling Interne Geneeskunde, Nijmegen, Not set
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Narodowy Instytut Onkologii-im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy - Nowotworow Pluca i Klatki Piersiowej, Warsaw, Mazowieckie
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Not set
Swietokrzyskie Centrum Onkologii, Kielce, Not set
Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Lodzi, Lodz, Not set
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwock, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan, Not set
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw, Not set
Hospital Pedro Hispano | Clinical Research Center, Matosinhos, Porto
Unidade Local Saúde Coimbra, E.P.E, Coimbra, Not set
Fundacao Champalimaud | Centro Clinico Champalimaud - Unidade Investigacao Clinica, Lisboa, Not set
CHULN - Hospital Pulido Valente, Lisboa, Not set
IPO Porto, Porto, Not set
Radiotherapy Center Cluj SRL, Flore?ti, Comuna Floresti
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu (IOB); Oncologie Medicala II, Bucuresti, Not set
Spitalul Clinic Coltea, Bucuresti, Not set
CardioMed S.R.L., Cluj-Napoca, Not set
Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca, Not set
Sc Oncolab Srl, Craiova, Not set
Centrul de Oncologie Sfantul Nectarie, Craiova, Not set
S.C Ovidius Clinical Hospital SRL - Oncology Department, Ovidiu, Not set
Oncocenter, Timisoara, Not set
Raffles Cancer Centre, Singapore, Not set
OncoCare Cancer Centre | Gleneagles Medical Centre, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Curie Oncology | Farrer, Singapore, Not set
POKO Poprad s.r.o., Poprad, Not set
Fakultna nemocnica Trnava, Trnava, Not set
Hospital Universitario Puerta De Hierro De Majadahonda - Oncologia, Majadahonda, Madrid
Complejo Hospitalario Universitario A Coruna (CHUAC), A Coruna, Not set
Institut Catala d'Oncologia (ICO) - Hospital Universitari Germans Trias i Pujol (HUGTP) Location, Badalona, Not set
Hospital Quiron Dexeus - Oncologia, Barcelona, Not set
Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona, Not set
Hospital General Universitario Gregorio Maranon | Oncologia, Madrid, Not set
Hospital Universitario Ramon Y Cajal - Oncologia, Madrid, Not set
Hospital Universitario Fundacion Jimenez Diaz- Oncology Service, Madrid, Not set
Hospital Universitario De Navarra - Oncologia, Pamplona, Not set
Fundacion Instituto Valenciano de Oncologia (IVO, Valencia, Not set
Hospital Universitario Y Politecnico La Fe - Oncologia, Valencia, Not set
Skåne University Hospital, Lund, Not set
Norrland University Hospital - Cancercentrum, Umeå, Not set
Kantonsspital Baden, Baden, Aargau
HFR Freiburg - Kantonsspital, Fribourg, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Kaohsiung
National Cheng Kung University Hospital, Tainan, TNN
Chung Shan Medical University Hospital, Taichung, Not set
Taichung Veterans General Hospital, Taichung, Not set
Chi-Mei Medical Center, Liouyine, Tainan, Not set
National Taiwan University Hospital (NTUH) - Cancer Research Center, Taipei, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Ankara Bilkent Sehir Hastanesi, Bilkent Ankara, Not set
Marmara University Hospital, Istanbul, Not set
Ege Universitesi Tip Fakultesi, Izmir, Not set
Istanbul Medeniyet Üniversitesi Göztepe Süleyman Yalçin Sehir Hastanesi, Kadikoy, Not set
I.A.Ü. VM Medical Park Florya Hastanesi, Kucukcekmece, Not set
Sakarya Universitesi Egitim ve Arastirma Hastanesi, Sakarya, Not set
Ankara Etlik Sehir Hastanesi, Yenimahalle, Not set
Adana Sehir Egitim ve Arastirma Hastanesi, Yuregir, Not set
LLC "RDP Ukraine" - Medical Department, Dnipro, Not set
Private Enterprise Private Production Company "Acinus", Treatment and Diagnostic Center, Kropyvnytskyi, Not set
Kyiv City Clinical Oncology Center - Department of Chemotherapy #1, Kyiv, Not set
Limited Liability Company "MedOffice Group Medical Center", Kyiv, Not set
Medical Center LLC "Verum Expert Clinic", Kyiv, Not set
Volyn Regional Oncology Center, Lutsk, Not set
Municipal Enterprise 'Rivne Regional Antitumor Center" of the Rivne Regional Council", Rivne, Not set
MNCE "Uzhhorod City Multidisciplinary Clinical Hospital" -Oncology Department, Uzhhorod, Not set
Torbay Hospital, Torquay, Devon
Belfast City Hospital, Belfast, North Ireland
Royal Surrey County Hospital, Guildford, Surrey
Velindre University NHS Trust | Velindre Cancer Centre - Clinical Trials Unit, Cardiff, Not set
Conditions: Advanced Non-small Cell Lung Cancer, HER2 Mutation
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
Active Not Recruiting
The main purpose of this study is to evaluate the efficacy and safety of ramucirumab or merestinib or placebo plus cisplatin and gemcitabine in participants with advanced or metastatic biliary tract cancer.
The main purpose of this study is to evaluate the efficacy and safety of ramucirumab or merestinib or placebo plus cisplatin and gemcitabine in participants with advanced or metastatic biliary tract cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: The University of Arizona Cancer Center, Tucson, Arizona +81 locations
The University of Arizona Cancer Center, Tucson, Arizona
UCSF Medical Center at Mission Bay, San Francisco, California
Georgetown University Medical Center, Washington, District of Columbia
University of Florida School of Medicine, Gainesville, Florida
Karmanos Cancer Institute, Detroit, Michigan
Washington University Medical School, Creve Coeur, Missouri
Washington University Medical School, Saint Louis, Missouri
Washington University Medical School, Saint Louis, Missouri
Washington University Medical School, Saint Peters, Missouri
Thomas Jefferson University, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Florida Cancer Specialists, Nashville, Tennessee
Tennessee Oncology PLLC, Nashville, Tennessee
Alexander Fleming, Caba, BS
Hospital de Gastroenterologia Udaondo, Capital Federal, Buenos Aires
Fundacion Ars Medica, San Salvador de Jujuy, Jujuy
Clinica Viedma, Viedma, Río Negro
Centro Medico San Roque, San Miguel de Tucumán, Tucumán
Fundacion Favaloro, Ciudad de Buenos Aires, Not set
Fundación CORI para la Investigación y Prevención del Cáncer, La Rioja, Not set
Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan, San Juan, Not set
Calvary Mater Newcastle, Waratah, New South Wales
Royal Adelaide Hospital, Adelaide, South Australia
Austin Health, Heidelberg, Victoria
Landesklinikum Wr. Neustadt, Wiener Neustadt, Niederösterreich
Universitätsklinikum Salzburg, Salzburg, Not set
KH der Barmherzigen Brüder Wien, Wien, Not set
Cliniques universitaires Saint-Luc, Bruxelles, Brussel
Universitair Ziekenhuis Gent, Gent, Not set
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Not set
Masarykuv onkologicky ustav, Brno, Brno-město
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set
Fakultni Nemocnice v Motole, Praha 5, Not set
Aarhus Universitetshospital, Aarhus Sygehus, Aarhus C, Not set
Odense Universitetshospital, Odense C, Not set
CHU de Bordeaux Hop St ANDRE, Bordeaux, Gironde
Centre Leon Berard, Lyon, Rhône-Alpes
CHU de Besancon Hopital Jean Minjoz, Besancon Cedex, Not set
Hôpital C. HURIEZ, Lille, Not set
CHRU de Montpellier-Hopital St Eloi, Montpellier Cedex 5, Not set
Centre Antoine-Lacassagne, Nice, Not set
Gustave Roussy, Villejuif Cedex, Not set
Universitätsklinikum Tübingen, Tübingen, Baden-Württemberg
Universitätsklinikum Ulm, Ulm, Baden-Württemberg
Universitätsklinikum Erlangen, Erlangen, Bayern
Medizinische Hochschule Hanover, Hannover, Niedersachsen
HELIOS Klinikum Berlin-Buch, Berlin, Not set
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set
Debreceni Egyetem Klinikai Kozpont Onkologiai Tanszek, Debrecen, Hajdu-Bihar
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, Not set
Asan Medical Center, Seoul, Korea
Seoul National University Hospital, Seoul, Seoul, Korea
Severance Hospital, Yonsei University Health System, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Arke Estudios Clinicos S.A. de C.V., Mexico, DF
Centro de Alta Especialidad Reumatologia Inv del Potosi SC, San Luis Potosi, Not set
Russian Scientific Center of Radiology and Surgical Technologies, St. Petersburg, Sankt-Peterburg
Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Not set
Blokhin Cancer Research Center, Moscow, Not set
Saint-Petersburg City Clinical Oncology Dispensary, Saint-Petersburg, Not set
Hospital Duran I Reynals, Hospitalet De Llobregat, Barcelona
Hospital Clínico Universitario de Valencia, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Clinico de San Carlos, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Skåne universitetssjukhus, Malmö, Not set
Karolinska Universitetssjukhuset i Solna, Stockholm, Not set
Chang Gung Memorial Hospital - Kaohsiung Branch, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
National Cheng-Kung Uni. Hosp., Tainan, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Memorial Hospital - Linkou, Taoyuan City, Not set
Baskent University Dr. Turgut Noyan Research and Training Center, Adana, Not set
Hacettepe University Faculty of Medicine, Ankara, Not set
Akdeniz University Medical Faculty, Antalya, Not set
Trakya University, Edirne, Not set
Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi Yerleskesi, Istanbul, Not set
University College Hospital - London, London, Greater London
The Christie NHS Foundation Trust, Manchester, Greater Manchester
Hammersmith Hospital, Acton, London
The Clatterbridge Cancer Centre, Bebbington, Merseyside
Royal Marsden Hospital, Sutton, Surrey
Conditions: Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Active Not Recruiting
A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of immunotherapy-based treatment combinations in patients with locally advanced unresectable or metastatic G/GEJ cancer (hereafter referred to as gastric cancer) and esophageal cancer. Two cohorts of patients with gastric cancer have been enrolled in parallel in this study: the second-line (2L) Gastric Cancer Cohort consists of patients with... Read More
A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of immunotherapy-based treatment combinations in patients with locally advanced unresectable or metastatic G/GEJ cancer (hereafter referred to as gastric cancer) and esophageal cancer. Two cohorts of patients with gastric cancer have been enrolled in parallel in this study: the second-line (2L) Gastric Cancer Cohort consists of patients with gastric cancer who have progressed after receiving a platinum-containing or fluoropyrimide-containing chemotherapy regimen in the first-line setting, and the first-line (1L) Gastric Cancer Cohort consists of patients with gastric cancer who have not received prior chemotherapy in this setting. In each cohort, eligible patients will be assigned to one of several treatment arms. Additionally, a cohort of patients with esophageal cancer who have not received prior systemic treatment for their disease will be enrolled in this study. Eligible patients will be randomized to chemotherapy or the combination of chemotherapy with checkpoint inhibitor immunotherapy. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/22/2025
Locations: Mayo Clinic Cancer Center, Scottsdale, Arizona +25 locations
Mayo Clinic Cancer Center, Scottsdale, Arizona
Uni of Southern California, Los Angeles, California
UCLA Jonsson Comprehensive Cancer Center, Santa Monica, California
Columbia University Medical Center, New York, New York
Tennessee Oncology - Nashville, Nashville, Tennessee
The University of Texas MD Anderson Cancer Center, Houston, Texas
Blacktown Hospital, Blacktown, New South Wales
Monash Medical Centre-Moorabbin Campus, Clayton, Victoria
Peter MacCallum Cancer Centre, Melbourne, Victoria
Rambam Health Care Campus, Haifa, Not set
Sourasky Medical Centre, Tel-Aviv, Not set
Seoul National University Bundang Hospital, Gyeonggi-do, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital (SNUH) - Medical Oncology Center, Seoul, Not set
Yonsei University College of Medicine (YUCM)-Yonsei Cancer Center, Seoul, Not set
University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC), Songpa-gu, Not set
The Catholic University of Korea St. Vincent's Hospital, Suwon-si,, Not set
Universidad de Navarra - Clinica Universitaria de Navarra (CUN), Pamplona, Navarra
Hospital Universitari Vall dHebron, Barcelona, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Beatson West of Scotland Cancer Centre, Glasgow, Not set
Barts and The London School of Medicine and Dentistry - Barts Cancer Institute (BCI)-CECM, London, Not set
The Royal Marsden, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
The Royal Marsden NHS Foundation Trust - Royal Marsden Hospital (RMH) - Sutton, Sutton, Not set
Conditions: Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
Active Not Recruiting
This randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with platinum-based in the adjuvant setting. Participants in the experimental arm will receive alectinib at 600 mg orally twice daily (BID) taken with food for 24 months.
Participants in the control arm will receive one of the protocol specified platinum based chemotherapy regimens for 4 cycles. Following treatment completion, participants will be... Read More
This randomized, active-controlled, multicenter, open-label, Phase III study is designed to investigate the efficacy and safety of alectinib compared with platinum-based in the adjuvant setting. Participants in the experimental arm will receive alectinib at 600 mg orally twice daily (BID) taken with food for 24 months.
Participants in the control arm will receive one of the protocol specified platinum based chemotherapy regimens for 4 cycles. Following treatment completion, participants will be followed up for their disease until disease recurrence. At the time of disease recurrence, participants will enter a survival follow-up until death, withdrawal of consent or study closure, whichever occurs earlier. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Rush University Medical Center, Chicago, Illinois +114 locations
Rush University Medical Center, Chicago, Illinois
MGH Cancer Center, Boston, Massachusetts
AHN Cancer Institute ? Allegheny General Hospital, Pittsburgh, Pennsylvania
Chris O'Brien Lifehouse, Camperdown, New South Wales
GenesisCare North Shore, St Leonards, New South Wales
Peter MacCallum Cancer Center, Melbourne, Victoria
Krankenhaus Nord - Klinik Floridsdorf, Wien, Not set
Healthcare Institution ?Gomel Regional Clinical Oncologic Dispensary?, Gomel, Homyel'skaya Voblasts'
Healthcare Institution Grodno University Hospital, Grodno, Hrodzyenskaya Voblasts'
Vitebsk Regional Clinical Oncology Dispensary, Vitebsk, Vitsyebskaya Voblasts'
Clinical center University of Sarajevo, Sarajevo, Not set
Beijing Cancer Hospital, Beijing, Not set
Jilin Cancer Hospital, Changchun, Not set
West China Hospital, Sichuan University, Chengdu, Not set
Fujian Medical University Union Hospital, Fujian, Not set
Guangdong General Hospital, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Shandong Cancer Hospital, Jinan, Not set
Shanghai Chest Hospital, Shanghai, Not set
Zhongshan Hospital Fudan University, Shanghai, Not set
Shenzhen People's Hospital, Shenzhen, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan City, Not set
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Not set
Odense Universitetshospital, Onkologisk Afdeling R, Odense C, Not set
Kasr Eieny Uni Hospital, Cairo, Not set
CHU Angers, Angers, Not set
Hopital Nord AP-HM, Marseille, Not set
Hopital Bichat Claude Bernard, Paris, Not set
Institut Gustave Roussy, Villejuif cedex, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH, Georgsmarienhütte, Not set
Thoraxklinik Heidelberg gGmbH, Heidelberg, Not set
Fachklinik für Lungenerkrankungen, Immenhausen, Not set
Metropolitan Hospital, Athens, Not set
Theageneio Hospital, Thessaloniki, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Hetenyi Geza County Hospital, Szolnok, Not set
Rambam Health Care Campus, Haifa, Not set
Meir Medical Center, Kfar Saba, Not set
Az. Osp. Monaldi, Napoli, Campania
Azienda Ospedaliera San Camillo Forlanini - Unità Operativa Complessa di Pneumologia Oncologica 1, Roma, Lazio
Irccs Istituto Europeo di Oncologia (IEO), Milano, Lombardia
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Piemonte
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia, Perugia, Umbria
Aichi Cancer Center, Aichi, Not set
National Cancer Center Hospital East, Chiba, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Hiroshima University Hospital, Hiroshima, Not set
National Hospital Organization Hokkaido Cancer Center, Hokkaido, Not set
National Hospital Organization Himeji Medical Center, Hyogo, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Kumamoto University Hospital, Kumamoto, Not set
Kyoto University Hospital, Kyoto, Not set
Sendai Kousei Hospital, Miyagi, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Okayama University Hospital, Okayama, Not set
Osaka City General Hospital, Osaka, Not set
Shizuoka Cancer Center, Shizuoka, Not set
National Cancer Center Hospital, Tokyo, Not set
Juntendo University Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Tokyo Medical University Hospital, Tokyo, Not set
Almaty Oncology Center, Almaty, Not set
National Cancer Center, Gyeonggi-do, Not set
Seoul National University Bundang Hospital, Gyeonggi-do, Not set
Ajou University Medical Center, Gyeonggi-do, Not set
Gachon University Gil Medical Center, Incheon, Not set
Chonnam National University Hwasun Hospital, Jeollanam-do, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
PHI University Clinic of Radiotherapy and Oncology; Malignant diseases of thorax, Skopje, Not set
Private Health Organization Acibadem Sistina Hospital, Skopje, Not set
Gdanski Uniwersytet Medyczny, Gda?sk, Not set
Krakowski Szpital Specjalistyczny im sw. Jana Paw?a II, Kraków, Not set
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, Poznan, Not set
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad, Warszawa, Not set
Prof Dr I Chiricuta Institute of Oncology, Cluj-napoca, Not set
Oncomed SRL, Timisoara, Not set
Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moskovskaja Oblast
FSBI Russian Oncology Research Center n.a. Blokhin of MOH RF, Moscow, Moskovskaja Oblast
P.A. Gertsen Cancer Research Inst., Moscow, Moskovskaja Oblast
SPb City Clin Onc Dsp, Sankt-peterburg, Sankt Petersburg
Pavlov First Saint Petersburg State Medical University, St. Petersburg, Sankt Petersburg
Scientific Research Oncology Institute named after N.N. Petrov, St. Petersburg, Sankt Petersburg
GUZ Regional clinical hospital # 1, Krasnodar, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
Hospital Universitari Germans Trias i Pujol, Barcelona, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Chang Gung Memorial Foundation - Kaohsiung, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
National Taiwan University Hospital, Taipei, Not set
Chang Gung Medical Foundation - Linkou, Taoyuan, Not set
Taichung Veterans General Hospital, Xitun Dist., Not set
Ramathibodi Hospital, Bangkok, Not set
Siriraj Hospital, Bangkok, Not set
Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital, Adana, Not set
Hacettepe Uni Medical Faculty Hospital, Ankara, Not set
Ankara Ataturk Chest Diseases Training and Research Hospital, Ankara, Not set
Istanbul Uni Cerrahpasa Medical Faculty Hospital, Istanbul, Not set
Ege Uni Medical Faculty Hospital, Izmir, Not set
Izmir Suat Seren Chest Diseases and Surgery Research Hospital, Izmir, Not set
Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, Malatya, Not set
Medikal Park Samsun, Samsun, Not set
Medical center of Yuriy Spizhenko LLC, Kapitanovka Village, KIEV Governorate
Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipropetrovsk, Not set
Kyiv City Clinical Oncological Center, Kyiv, Not set
RCI Sumy Regional Clinical Oncological Dispensary, Sumy, Not set
Vinnytsia Regional Clinical Oncology Dispensary, Vinnytsia, Not set
Guys Hospital, London, Not set
Wythenshaw Hospital, Manchester, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
25 - 36 of 298